anti-HMFG1 antibody product blog
Tags: Antibody; Monoclonal Antibody; HMFG1; anti-HMFG1 antibody;
The HMFG1 n/a (Catalog #MBS530694) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The HMFG1 antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s HMFG1 can be used in a range of immunoassay formats including, but not limited to, Immunohistochemistry (IHC) Paraffin, Immunoprecipitation (IP), Western Blot (WB).IHC-P: 1:50
IP: 2 ug/mg
WB: 0.5-1 ug/ml. Researchers should empirically determine the suitability of the HMFG1 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal HMFG1 antibody.
Biological Significance: Human Milk Fat Globule 1 (MFG1) is a membrane protein present on normal human breast epithelial cells and cell lines derived from breast carcinomas. Human MFG1 is also localised on the surface of the human milk fat globule. HMFG1 is a differentiation marker and specific breast epithelial marker in normal and neoplastic mammary development. Biohazard Information: This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
Immunogen: HMFG1 antibody was raised in mouse using delipidated human milk fat globule membrane preparation as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing HMFG1 are readily searchable from our website. Different antibodies against the same target such as HMFG1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.